恒瑞医药：上半年实现净利润26.68亿元同比增长0.21%_老虎社区_美港股上老虎

恒瑞医药：上半年实现净利润26.68亿元同比增长0.21%

新浪财经2021-08-19

投资研报

【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）

牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）

揭秘：1个月暴涨60%！为什么东方证券能成为龙一？

【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）

　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。

股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张熠

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

jamiengan
·2021-08-19
🙃🙃🙃
回复
1
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2160763716?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","is_english":false,"pubTime":"2021-08-19 17:23","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2160763716","market":"us","top_or_hot":-1,"title":"恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%","media":"新浪财经","content":"<html><body><div>\n<blockquote>\n<p>投资研报</p>\n<p>【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）</p>\n<p>牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）</p>\n<p>揭秘：1个月暴涨60%！为什么<a href=\"https://laohu8.com/S/600958\">东方证券</a>能成为龙一？</p>\n<p>【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）</p>\n</blockquote><p>　　8月19日消息，<span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span><span></span>：上半年实现净利润26.68亿元，同比增长0.21%。</p>\n<div> </div>\n<div>\n<span>股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿&gt;&gt;</span>\n<img src=\"\"/>\n</div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n<p>责任编辑：张熠 </p>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 17:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600276","symbol_name":"恒瑞医药","start_time":0,"source_url":"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml","article_id":"2160763716","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2160763716","pubTimestamp":1629364980,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600276":"恒瑞医药"},"translate_title":"Jiangsu Hengrui Medicine Co.,Ltd.: The net profit in the first half of the year was 2.668 billion yuan, a year-on-year increase of","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600276":1},"content_text":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":838324219,"gmtCreate":1629376524131,"gmtModify":1631890211776,"author":{"id":"3569299384564621","authorId":"3569299384564621","name":"jamiengan","avatar":"https://static.tigerbbs.com/889f4395dbbcc2004e91811498c78b43","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569299384564621","authorIdStr":"3569299384564621"},"htmlText":"🙃🙃🙃","listText":"🙃🙃🙃","text":"🙃🙃🙃","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/838324219","repostId":2160763716,"repostType":2,"repost":{"id":"2160763716","kind":"news","pubTimestamp":1629364980,"share":"https://www.laohu8.com/m/news/2160763716?lang=&edition=full","pubTime":"2021-08-19 17:23","market":"us","language":"zh","title":"恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2160763716","media":"新浪财经","summary":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","content":"<html><body><div>\n<blockquote>\n<p>投资研报</p>\n<p>【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）</p>\n<p>牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）</p>\n<p>揭秘：1个月暴涨60%！为什么<a href=\"https://laohu8.com/S/600958\">东方证券</a>能成为龙一？</p>\n<p>【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）</p>\n</blockquote><p>　　8月19日消息，<span><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a></span><span></span>：上半年实现净利润26.68亿元，同比增长0.21%。</p>\n<div> </div>\n<div>\n<span>股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿&gt;&gt;</span>\n<img src=\"\"/>\n</div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n<p>责任编辑：张熠 </p>\n</div></body></html>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药：上半年实现净利润26.68亿元 同比增长0.21%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 17:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","relate_stocks":{"600276":"恒瑞医药"},"source_url":"https://finance.sina.com.cn/stock/s/2021-08-19/doc-ikqcfncc3815076.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2160763716","content_text":"投资研报\n【主力资金】总龙头霸气打出8+1板！重磅利好盘后来袭，这类个股值得关注（附受益股）\n牛市旗手爆发涨停潮：财富管理赛道三大投资机遇受益股曝光！3股上涨目标价明确（名单）\n揭秘：1个月暴涨60%！为什么东方证券能成为龙一？\n【机构调研】袁芳、杨瑨、归凯等大佬齐出手调研1股！这一类股投资机会值得重视（受益股）\n　　8月19日消息，恒瑞医药：上半年实现净利润26.68亿元，同比增长0.21%。\n \n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张熠","news_type":1,"symbols_score_info":{"600276":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}